EVA MARÍA
CIRUELOS GIL
Profesora asociada de Ciencias de la Salud
Hospital San Pedro de Alcántara
Cáceres, EspañaPublicaciones en colaboración con investigadores/as de Hospital San Pedro de Alcántara (3)
2020
2019
-
Safety of eribulin as third-line chemotherapy in HER2-negative, advanced breast cancer pre-treated with taxanes and anthracycline: OnSITE study
Breast Journal, Vol. 25, Núm. 2, pp. 219-225
2016
-
Single arm, multicentre, non-randomized open-label trial to evaluate the safety of eribulin in third line chemotherapy in patients with HER2-negative metastatic or locally advanced breast cancer previously treated with anthracyclines and taxanes: Onsite study (ONCOSUR 2012-02)
Annals of Oncology, Vol. 27, pp. vi76